Valuation of a manufacturing cie @ Assets value or @ EBITDA multiple?

February 06, 2025
by a searcher from Université de Sherbrooke in Montreal, QC, Canada
I'm looking at acquiring a health supplement manufacturing company.
The company has 3.2M$ worth of assets but generates only 600K EBITDA / year. The company operates at roughly 15% its production capacity right now.
The seller values his company at 3.8M$, which is value of assets + some intangibles (IP, etc.)
Is valuation @ Assets value the right way to value a manufacturing company?
> If so, should I pay for 100% of the evaluator's valuation, or lower?
Should I value @EBITDA multiple ?
> If so, what multiple should I benchmark on?
Thanks!
from Emory University in Tucson, AZ, USA
in Toronto, ON, Canada